D-P Wu - JoVE Visualize

Showing results (41-50 of 107) with videos related to

Pageof 11

Sort By:

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 20, 2016

[The role of Tim-3 mRNA in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]X L Li, Y Yao, B Y Yang, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 21, 2016

[Establishment and assessment of a nomogram for predicting the differentiation syndrome of acute promyelocytic leukemia]X B Bao, X H Hu, C Y Tian, et al.

Leukemia|June 24, 2017

Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplantsY Wang, D-P Wu, Q-F Liu, et al.

Zhonghua Yi Xue Za Zhi|January 5, 2024

[Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma]S Z Liu, X P Zong, W Z Cai, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 19, 2016

[The impact of HLA haplotype and alleles mismatches of donor-recipient pairs on outcome of haploidentical hematopoietic stem cell transplantation with a third part cord blood unit]W J Zhu, J He, X J Bao, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 3, 2016

[Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review]W Han, Y Han, J Chen, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 5, 2026

[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population]L Xuan, H Huang, L P Xu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 2, 2016

[Efficacy and safety of JAK inhibitor ruxolitinib in Chinese patients with myelofibrosis: results of a 1-year follow-up of A2202]J Jin, X Du, D B Zhou, et al.

Zhonghua Nei Ke Za Zhi|January 28, 2022

[Efficacy and safety of venetoclax combined with azacitidine versus CAG regimen combined with decitabine in elderly patients with relapsed acute myeloid leukemia]P Wang, L W Zhang, C Q Lu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 1, 2024

[Clinical efficacy and safety of blinatumomab bridging CAR-T cell therapy in the treatment of patients with adult acute B-cell lymphoblastic leukemia]Y Pu, X Y Zhou, Y Liu, et al.

Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:

Pageof 11

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 20, 2016

[The role of Tim-3 mRNA in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]X L Li, Y Yao, B Y Yang, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 21, 2016

[Establishment and assessment of a nomogram for predicting the differentiation syndrome of acute promyelocytic leukemia]X B Bao, X H Hu, C Y Tian, et al.

Leukemia|June 24, 2017

Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplantsY Wang, D-P Wu, Q-F Liu, et al.

Zhonghua Yi Xue Za Zhi|January 5, 2024

[Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma]S Z Liu, X P Zong, W Z Cai, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 19, 2016

[The impact of HLA haplotype and alleles mismatches of donor-recipient pairs on outcome of haploidentical hematopoietic stem cell transplantation with a third part cord blood unit]W J Zhu, J He, X J Bao, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 3, 2016

[Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review]W Han, Y Han, J Chen, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 5, 2026

[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population]L Xuan, H Huang, L P Xu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 2, 2016

[Efficacy and safety of JAK inhibitor ruxolitinib in Chinese patients with myelofibrosis: results of a 1-year follow-up of A2202]J Jin, X Du, D B Zhou, et al.

Zhonghua Nei Ke Za Zhi|January 28, 2022

[Efficacy and safety of venetoclax combined with azacitidine versus CAG regimen combined with decitabine in elderly patients with relapsed acute myeloid leukemia]P Wang, L W Zhang, C Q Lu, et al.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 1, 2024

[Clinical efficacy and safety of blinatumomab bridging CAR-T cell therapy in the treatment of patients with adult acute B-cell lymphoblastic leukemia]Y Pu, X Y Zhou, Y Liu, et al.

Pageof 11